1. 1319PPost-hoc analysis of CLARINET phase III study to investigate the influence of diabetic status on progression-free survival (PFS) of patients with neuroendocrine tumours (NETs) treated with lanreotide (LAN) or placebo (PBO). (23rd October 2018) Authors: Pusceddu, S; Vernieri, C; Di Maio, M; Prinzi, N; Torchio, M; Buzzoni, R; Truong-Thanh, X-M; Mazzaferro, V; de Braud, F G M Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1692PPhysicians' knowledge, attitudes and practice towards fertility and pregnancy-related issues in BRCA-mutated breast cancer (BC) patients (pts): Results from the BCY3/BCC 2017 survey. (23rd October 2018) Authors: Lambertini, M; Di Maio, M; Poggio, F; Pagani, O; Curigliano, G; Del Mastro, L; Paluch-Shimon, S; Loibl, S; Partridge, A H; Azim, H A; Peccatori, F A; Demeestere, I Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 4CPS-147 Real world data (rwd) analysis on use of immunecheckpoint inhibitors (ici) for non-small-cell lung cancer (NSCLC). Issue 1 (23rd March 2023) Authors: Masucci, S; Salerno, F; Ricci, L; Bellero, M; Bianco, A; Fazzina, GF; Sorrenti, O; Lacidogna, G; Di Maio, M; Gasco, A Journal: European journal of hospital pharmacy Issue: Volume 30:Issue 1(2023)supplement 1 Page Start: A71 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 4CPS-285 Multidisciplinary oral therapy outpatient clinic: an Italian single centre experience. (14th March 2021) Authors: Fazzina, G; Bellero, M; Marino, D; Terzolo, S; Sperti, E; Zichi, C; Codegone, F; Paratore, C; Ciriolo, G; Di Maio, M; Gasco, A Journal: European journal of hospital pharmacy Issue: Volume 28(2021)Supplement 1 Page Start: A57 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 52P Chronic and late-onset toxicities from immune checkpoints inhibitors (ICIs): Analysis of the publications leading to ICIs approval between 2011 and 2019. (15th December 2019) Authors: Ghisoni, E; Marandino, L; Valabrega, G; Aglietta, M; Di Maio, M Journal: Annals of oncology Issue: Volume 30(2019)Supplement 11 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 78P A systematic review and meta-analysis of trials assessing activity of PD-1/PD-L1 immune checkpoint inhibitors (ICIs) for pre-treated advanced malignant mesothelioma (aMM). (15th December 2019) Authors: Tagliamento, M; Bironzo, P; De Luca, E; Pignataro, D; Rapetti, S G; Audisio, M; Bertaglia, V; Paratore, C; Bungaro, M; Olmetto, E; Artusio, E; Reale, M L; Zichi, C; Capelletto, E; Carnio, S; Buffoni, L; Passiglia, F; Novello, S; Di Maio, M Journal: Annals of oncology Issue: Volume 30(2019)Supplement 11 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Clinical outcome of patients with ST-elevation myocardial infarction and angiographic evidence of coronary artery ectasia. (25th November 2020) Authors: Silverio, A; Esposito, L; Fierro, G; Di Maio, M; Di Feo, F; Iannicelli, A; Varone, M; Vigorito, F; Maione, A; Di Muro, M.R; Attisano, T; Vecchione, C; Galasso, G; Baldi, C Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Deficiencies in health-related quality-of-life assessment and reporting: a systematic review of oncology randomized phase III trials published between 2012 and 2016. (10th October 2018) Authors: Marandino, L; La Salvia, A; Sonetto, C; De Luca, E; Pignataro, D; Zichi, C; Di Stefano, R F; Ghisoni, E; Lombardi, P; Mariniello, A; Reale, M L; Trevisi, E; Leone, G; Muratori, L; Marcato, M; Bironzo, P; Novello, S; Aglietta, M; Scagliotti, G V; Perrone, F Journal: Annals of oncology Issue: Volume 29:Number 12(2018) Page Start: 2288 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Echocardiographic probability of pulmonary hypertension according to the direct and indirect signs: a validation study. (14th October 2021) Authors: D'Alto, M; Di Maio, M; Romeo, E; Argiento, P; Blasi, E; Di Vilio, A; Abbate, M; D'Andrea, A; Naeije, R; Golino, P Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Echocardiographic probability of pulmonary hypertension according to the old and the new definition: a validation study. (3rd October 2022) Authors: D'Alto, M; Di Maio, M; Romeo, E; Argiento, P; Di Vilio, A; Blasi, E; Vergara, A; Rea, G; D'Andrea, A; Golino, P; Naeije, R Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗